Novel Coronavirus (SARS-CoV-2/COVID-19)
In-hospital mortality among patients hospitalized primarily for COVID-19 fell from 15.1% during the delta period to 4.9% this April through June, the Centers for Disease Control and Prevention reported this week.
As labor shortages and inflation drive up expenses, U.S. hospitals and health systems this year face the worst financial crisis since the COVID-19 pandemic began, according to a report prepared for AHA by Kaufman Hall.
The CDC recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna’s updated COVID-19 vaccine booster for Americans aged 18 and older, as recommended by its vaccine advisory committee.
Medicare patients who accessed opioid use disorder treatment through telehealth services during the pandemic were more likely to stay in treatment and less likely to experience an overdose than patients without telehealth access to OUD treatment, according to a federal study published last week in…
Novavax today announced the Food and Drug Administration expanded the emergency use authorization for its Adjuvanted (NVX-CoV2373) COVID-19 vaccine. Under the expanded EUA, the two-dose primary series can be administered for adolescents between the ages of 12 and 17.
The Centers for Medicare…
In mid-December, hospitals will transition to reporting COVID-19 data via the Centers for Disease Control and Prevention’s National Healthcare Safety Network, which will assume responsibility for collecting the data when the Department of Health and Human Services’ contract with TeleTracking…
The Department of Health and Human Services (HHS) has announced that the Centers for Disease Control and Prevention (CDC) will assume responsibility for the collection of hospital COVID-19 data, beginning in mid-December 2022.
At the outset of the COVID-19 pandemic, communities across America entered mandatory quarantines and temporarily shut down many every day services such as schools, retail stores and libraries.
The Department of Health and Human Services yesterday released new guidance on ordering, reporting, payment and cost-sharing for the COVID-19 monoclonal antibody therapy bebtelovimab, a treatment option for outpatients at high risk for hospitalization that begins transitioning from HHS to…